ANVISA-2020-0065-V365

Type IA variation for application ANVISA-2020-0065. Type IA variation: Formulation Change for Immunovant-α — routine update

Variation Number
ANVISA-2020-0065-V365
Type
Type IA
Application
ANVISA-2020-0065
Change
CHG-2024-0065
Status
In Progress
Fee
€4,621
Submitted
—
Approved
—
Description

Type IA variation: Formulation Change for Immunovant-α — routine update